Yvonne Huber

6PUBLICATIONS
10CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Exercise physiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 26, 2025
Incidence of major cardiovascular events in patients with metabolic dysfunction-associated steatotic liver disease in the general population.

Yvonne Huber, Lea Hofmann, Jürgen H Prochaska

|Mar 27, 2025
Immunotherapy as a new perspective for the therapy of esophageal cancer.

Yvonne Huber, Markus Moehler, Anica Högner

|Jul 26, 2019
Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program.

Yvonne Huber, Daniel Pfirrmann, Ines Gebhardt

|Jan 04, 2019
Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study.

Daniel Pfirrmann, Yvonne Huber, Jörn Markus Schattenberg

Pageof 1